South Korea approves remdesivir for virus patients

SEOUL (HRNW) – South Korea on Wednesday issued an emergency authorisation for the anti-viral drug remdesivir to be used to treat coronavirus patients, paving the way for imports.

The US authorised the emergency use of remdesivir in hospitals at the start of May, followed by Japan, while Europe has been considering following suit.

A South Korean government review of remdesivir research said it had proven “clinically meaningful” in cutting patients’ recovery times, the food and drug safety ministry said.

It will work with manufacturer Gilead Sciences to expedite the first shipment of imports, it added, without offering further details of pricing or quantities.


Be the first to comment on "South Korea approves remdesivir for virus patients"

Leave a comment

Your email address will not be published.